18 November 2017
News and Views
Links and Services
Inflammatory markers are associated with a risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs, reports the latest issue of Gastroenterology.
Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) lower the risk of colorectal cancer.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors